Immune Checkpoint Inhibitor-Associated Systemic Sclerosis in the Treatment of a Small Cell Lung Cancer Patient with Durvalumab: A Case Report

Immune Checkpoint Inhibitor-Associated Systemic Sclerosis in the Treatment of a Small Cell Lung Cancer Patient with Durvalumab: A Case Report

De-Hu Li, Xian-Zhi Xiong Department of Pulmonary and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Xian-Zhi Xiong, Email xxz0508@hust.edu.cnAbst...

Full description

Bibliographic Details
Main Authors: Li DH, Xiong XZ
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
systemic sclerosis
durvalumab
small cell lung cancer
immune checkpoint inhibitors
immune-related adverse events
Online Access:https://www.dovepress.com/immune-checkpoint-inhibitor-associated-systemic-sclerosis-in-the-treat-peer-reviewed-fulltext-article-CCID

Internet

https://www.dovepress.com/immune-checkpoint-inhibitor-associated-systemic-sclerosis-in-the-treat-peer-reviewed-fulltext-article-CCID

Similar Items